ONCT - Oncternal Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

ONCT is currently covered by 4 analysts

Oncternal Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of ONCT is 61.54% BUY and 38.46% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 22.86% of the time, taking 40.6 days on average.

Highest price target for ONCT is $18, Lowest price target is $4.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 12-Aug-2024. First documented stock forecast 10-Aug-2020.

Best performing analysts who are covering ONCT - Oncternal Therapeutics:

Hartaj Singh Li Watsek Raghuram Selvaraju Naureen Quibria Kemp Dolliver

Currently out of the existing stock ratings of ONCT, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$18

$19

2 years 3 months 8 days ago
(12-Aug-2024)

1/7 (14.29%)

$13.83 (331.65%)

190

Buy

$2

2 years 11 months 17 days ago
(04-Dec-2023)

0/1 (0%)

$-5 (-71.43%)

Hold

$26

3 years 2 months 13 days ago
(07-Sep-2023)

0/2 (0%)

$20 (333.33%)

Hold

$70

3 years 7 months 16 days ago
(04-Apr-2023)

0/1 (0%)

$50 (250.00%)

Hold

$9

3 years 7 months 17 days ago
(04-Apr-2023)

1/1 (100%)

$-5.2 (-36.62%)

13

Show more analysts

Please expand the browser size to see the chart

What is ONCT (Oncternal Therapeutics) average time for price targets to be met?

On average it took 41 days for the stock forecasts to be reached, with an average price target met ratio of 22.86%.

Which analyst most recently updated their price target on ONCT (Oncternal Therapeutics)?

Raghuram Selvaraju

Which analyst has the lowest performance score on ONCT (Oncternal Therapeutics) with a proven track record?

KEMP DOLLIVER

Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 17 price targets and 8 ratings on ONCT

Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?

Li Watsek with the highest potential upside of $24.86

Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?

Kemp Dolliver with the lowest potential downside of -$5.6
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?